Literature DB >> 30768864

Collagen XIII and Other ECM Components in the Assembly and Disease of the Neuromuscular Junction.

Anne Heikkinen1, Heli Härönen1, Oula Norman1, Taina Pihlajaniemi1.   

Abstract

Alongside playing structural roles, the extracellular matrix (ECM) acts as an interaction platform for cellular homeostasis, organ development, and maintenance. The necessity of the ECM is highlighted by the diverse, sometimes very serious diseases that stem from defects in its components. The neuromuscular junction (NMJ) is a large peripheral motor synapse differing from its central counterparts through the ECM included at the synaptic cleft. Such synaptic basal lamina (BL) is specialized to support NMJ establishment, differentiation, maturation, stabilization, and function and diverges in molecular composition from the extrasynaptic ECM. Mutations, toxins, and autoantibodies may compromise NMJ integrity and function, thereby leading to congenital myasthenic syndromes (CMSs), poisoning, and autoimmune diseases, respectively, and all these conditions may involve synaptic ECM molecules. With neurotransmission degraded or blocked, muscle function is impaired or even prevented. At worst, this can be fatal. The article reviews the synaptic BL composition required for assembly and function of the NMJ molecular machinery through the lens of studies primarily with mouse models but also with human patients. In-depth focus is given to collagen XIII, a postsynaptic-membrane-spanning but also shed ECM protein that in recent years has been revealed to be a significant component for the NMJ. Its deficiency in humans causes CMS, and autoantibodies against it have been recognized in autoimmune myasthenia gravis. Mouse models have exposed numerous details that appear to recapitulate human NMJ phenotypes relatively faithfully and thereby can be readily used to generate information necessary for understanding and ultimately treating human diseases. Anat Rec, 2019.
© 2019 Wiley Periodicals, Inc. © 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  collagen XIII; myasthenic syndrome; neuromuscular junction; synaptic basal lamina

Mesh:

Substances:

Year:  2019        PMID: 30768864     DOI: 10.1002/ar.24092

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  7 in total

1.  Engineering skeletal muscle tissues with advanced maturity improves synapse formation with human induced pluripotent stem cell-derived motor neurons.

Authors:  Jeffrey W Santoso; Xiling Li; Divya Gupta; Gio C Suh; Eric Hendricks; Shaoyu Lin; Sarah Perry; Justin K Ichida; Dion Dickman; Megan L McCain
Journal:  APL Bioeng       Date:  2021-07-13

Review 2.  Skeletal Muscle Extracellular Matrix - What Do We Know About Its Composition, Regulation, and Physiological Roles? A Narrative Review.

Authors:  Robert Csapo; Matthias Gumpenberger; Barbara Wessner
Journal:  Front Physiol       Date:  2020-03-19       Impact factor: 4.566

3.  A muscle-epidermis-glia signaling axis sustains synaptic specificity during allometric growth in Caenorhabditis elegans.

Authors:  Jiale Fan; Tingting Ji; Kai Wang; Jichang Huang; Mengqing Wang; Laura Manning; Xiaohua Dong; Yanjun Shi; Xumin Zhang; Zhiyong Shao; Daniel A Colón-Ramos
Journal:  Elife       Date:  2020-04-07       Impact factor: 8.140

4.  Integrin α11β1 is a receptor for collagen XIII.

Authors:  Jarkko Koivunen; Hongmin Tu; Antti Kemppainen; Padmanabhan Anbazhagan; Mikko A Finnilä; Simo Saarakkala; Jarmo Käpylä; Ning Lu; Anne Heikkinen; André H Juffer; Jyrki Heino; Donald Gullberg; Taina Pihlajaniemi
Journal:  Cell Tissue Res       Date:  2020-12-11       Impact factor: 5.249

Review 5.  Multiple MuSK signaling pathways and the aging neuromuscular junction.

Authors:  Lauren A Fish; Justin R Fallon
Journal:  Neurosci Lett       Date:  2020-04-28       Impact factor: 3.046

6.  Intramuscular Delivery of Gene Therapy for Targeting the Nervous System.

Authors:  Andrew P Tosolini; James N Sleigh
Journal:  Front Mol Neurosci       Date:  2020-07-17       Impact factor: 5.639

7.  Myasthenia Gravis: From the Viewpoint of Pathogenicity Focusing on Acetylcholine Receptor Clustering, Trans-Synaptic Homeostasis and Synaptic Stability.

Authors:  Masaharu Takamori
Journal:  Front Mol Neurosci       Date:  2020-05-28       Impact factor: 5.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.